Search Results

There are 28691 results for: content related to: Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy

  1. You have free access to this content
    An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 445–453, Sarah B. Fisher, Sameer H. Patel, Pelin Bagci, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley III, N. Volkan Adsay and Shishir K. Maithel

    Version of Record online : 8 MAY 2012, DOI: 10.1002/cncr.27619

  2. Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer

    Head & Neck

    Volume 35, Issue 6, June 2013, Pages: 852–857, Kimberly Johung, Amar Rewari, Hao Wu, Benjamin Judson, Joseph N. Contessa, Bruce G. Haffty and Roy H. Decker

    Version of Record online : 28 JUN 2012, DOI: 10.1002/hed.23041

  3. You have free access to this content
    Exploring biomarkers in head and neck cancer

    Cancer

    Volume 118, Issue 16, 15 August 2012, Pages: 3882–3892, Corey J. Langer

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.26718

    Corrected by:

    Erratum: Erratum: Exploring biomarkers in head and neck cancer

    Vol. 118, Issue 23, 6014, Version of Record online: 8 MAY 2012

  4. You have free access to this content
    Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: Evidence from an individual patient analysis

    Cancer

    Volume 118, Issue 9, 1 May 2012, Pages: 2525–2531, George R. Simon, Michael J. Schell, Mubeena Begum, Jongphil Kim, Alberto Chiappori, Eric Haura, Scott Antonia and Gerold Bepler

    Version of Record online : 25 OCT 2011, DOI: 10.1002/cncr.26522

  5. Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy

    International Journal of Urology

    Volume 24, Issue 3, March 2017, Pages: 230–235, Nagahide Matsumura, Yasushi Nakamura, Yasuo Kohjimoto, Satoshi Nishizawa, Kazuro Kikkawa, Akinori Iba, Yoshiki Kodama and Isao Hara

    Version of Record online : 9 JAN 2017, DOI: 10.1111/iju.13274

  6. You have free access to this content
    Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma

    Cancer

    Volume 119, Issue 17, 1 September 2013, Pages: 3242–3250, Malcolm H. Squires III, Sarah B. Fisher, Kevin E. Fisher, Sameer H. Patel, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley III, Alton B. Farris III and Shishir K. Maithel

    Version of Record online : 29 MAY 2013, DOI: 10.1002/cncr.28175

  7. You have free access to this content
    The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy

    BJU International

    Volume 108, Issue 2b, July 2011, Pages: E110–E116, Nagahide Matsumura, Yasushi Nakamura, Yasuo Kohjimoto, Takeshi Inagaki, Yoshihito Nanpo, Hironao Yasuoka, Yasuo Ohashi and Isao Hara

    Version of Record online : 16 DEC 2010, DOI: 10.1111/j.1464-410X.2010.09932.x

  8. You have full text access to this Open Access content
    Response to gemcitabine–platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non-small-cell lung cancer

    Thoracic Cancer

    Volume 3, Issue 1, February 2012, Pages: 19–26, In-Jae Oh, Hee-Jung Ban, Kyu-Sik Kim, Sang-Yun Song, Kook-Joo Na, Yun-Hyeon Kim, Sung-Ja Ahn, Song Choi, Hyun-Ju Cho and Young-Chul Kim

    Version of Record online : 5 FEB 2012, DOI: 10.1111/j.1759-7714.2011.00082.x

  9. Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 4, July/August 2008, Pages: 702–710, K.D. STEFFENSEN, M. WALDSTRØM, U. JEPPESEN, I. BRANDSLUND and A. JAKOBSEN

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1525-1438.2007.01068.x

  10. You have free access to this content
    ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy

    Cancer

    Volume 113, Issue 6, 15 September 2008, Pages: 1379–1386, In Gyu Hwang, Myung Ju Ahn, Byeong Bae Park, Yong Chan Ahn, Joungho Han, Seungkoo Lee, Jhingook Kim, Young Mog Shim, Jin Seok Ahn and Keunchil Park

    Version of Record online : 12 JUL 2008, DOI: 10.1002/cncr.23693

  11. You have full text access to this OnlineOpen article
    ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

    The Journal of Pathology: Clinical Research

    Volume 2, Issue 4, October 2016, Pages: 234–246, Mathilde Gay-Bellile, Pierre Romero, Anne Cayre, Lauren Véronèse, Maud Privat, Shalini Singh, Patricia Combes, Fabrice Kwiatkowski, Catherine Abrial, Yves-Jean Bignon, Philippe Vago, Frédérique Penault-Llorca and Andreï Tchirkov

    Version of Record online : 13 JUL 2016, DOI: 10.1002/cjp2.52

  12. ERCC1 expression in aseptic loosening after total hip replacement

    Journal of Biomedical Materials Research Part A

    Volume 92A, Issue 2, February 2010, Pages: 556–562, Stefan Landgraeber, Marius von Knoch, Franz Löer, Alexander Wegner, Michael Tsokos, Kurt Werner Schmid and Martin Totsch

    Version of Record online : 20 FEB 2009, DOI: 10.1002/jbm.a.32391

  13. mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines

    Respirology

    Volume 13, Issue 4, June 2008, Pages: 510–517, Junichi SHIMIZU, Yoshitsugu HORIO, Hirotaka OSADA, Toyoaki HIDA, Yoshinori HASEGAWA, Kaoru SHIMOKATA, Takashi TAKAHASHI, Yoshitaka SEKIDO and Yasushi YATABE

    Version of Record online : 21 MAY 2008, DOI: 10.1111/j.1440-1843.2008.01302.x

  14. You have free access to this content
    p38 mitogen-activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients

    Cancer

    Volume 118, Issue 20, 15 October 2012, Pages: 5015–5025, David Planchard, Valérie Camara-Clayette, Nicolas Dorvault, Jean-Charles Soria and Pierre Fouret

    Version of Record online : 13 MAR 2012, DOI: 10.1002/cncr.27510

  15. You have free access to this content
    Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas

    International Journal of Cancer

    Volume 126, Issue 8, 15 April 2010, Pages: 1944–1954, Hua-Yun Chen, Cui-Jie Shao, Fu-Rong Chen, Aij-Lie Kwan and Zhong-Ping Chen

    Version of Record online : 22 JUL 2009, DOI: 10.1002/ijc.24772

  16. You have free access to this content
    DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma

    Cancer

    Volume 117, Issue 14, 15 July 2011, Pages: 3201–3208, Ji-Youn Han, Kyong-Ah Yoon, Jae Hee Park, Young Joo Lee, Geon Kook Lee, Jong Hee Han, Sung Jin Yoon, Tak Yun, Heung Tae Kim and Jin Soo Lee

    Version of Record online : 24 JAN 2011, DOI: 10.1002/cncr.25863

  17. You have free access to this content
    Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

    Cancer

    Volume 121, Issue 16, August 15, 2015, Pages: 2720–2729, Edwin P. Hui, Brigette B. Y. Ma, K. C. Allen Chan, Charles M. L. Chan, Cesar S. C. Wong, Ka Fai To, Anthony W. H. Chan, Stewart Y. Tung, Wai-Tong Ng, Ashley C. Cheng, Victor H. F. Lee, Stephen L. Chan, Herbert H. F. Loong, Michael K. M. Kam, Sing-Fai Leung, Rosalie Ho, Frankie Mo, Roger K. C. Ngan and Anthony T. C. Chan

    Version of Record online : 6 MAY 2015, DOI: 10.1002/cncr.29413

  18. Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype

    Respirology

    Volume 17, Issue 1, January 2012, Pages: 127–133, MANALJAV TSEDEN-ISH, YOO-DUK CHOI, HYUN-JU CHO, HEE-JUNG BAN, IN-JAE OH, KYU-SIK KIM, SANG-YUN SONG, KOOK-JOO NA, SUNG-JA AHN, SONG CHOI and YOUNG-CHUL KIM

    Version of Record online : 21 DEC 2011, DOI: 10.1111/j.1440-1843.2011.02060.x

  19. Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy

    APMIS

    Volume 118, Issue 12, December 2010, Pages: 941–948, KYOUNG Ha KIM, IN-GU DO, HYEONG SU KIM, MYUNG HEE CHANG, HYO SONG KIM, HYUN JUNG JUN, JIEUN UHM, SEONG YOON YI, DO HYOUNG LIM, SANG HOON JI, MIN JAE PARK, JEEYUN LEE, SE HOON PARK, GHEE YOUNG KWON and HO YEONG LIM

    Version of Record online : 25 OCT 2010, DOI: 10.1111/j.1600-0463.2010.02648.x

  20. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines

    Cell Biology International

    Volume 33, Issue 10, October 2009, Pages: 1111–1117, Zhi-Gang Liu, Hua-Yun Chen, Jing-Jian Cheng, Zhong-Ping Chen, Xiao-Nan Li and Yun-fei Xia

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2009.07.004